EMA Withdrawn: Clopidogrel 1A Pharma (clopidogrel) — Acino Pharma GmbH

View source ↗

Summary

EMA has withdrawn Clopidogrel 1A Pharma (clopidogrel) from Acino Pharma GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Vascular Disease

Drugs mentioned

• Clopidogrel 1A Pharma (clopidogrel)

Snippet

Status: Withdrawn. Therapeutic area: Peripheral Vascular Diseases. MAH: Acino Pharma GmbH. Decision date: 01/02/2011